Home  |  Library  |  PRIME  |  Newsroom  |  E-mail  |  Directions

Tracey Elizabeth Wilson, Ph.D.

Recent Publications

1. Wilson TE, Jaccard J, Endias R, Minkoff H. Reducing the risk of HIV Infection for women: An attitudinal analysis of condom-carrying behavior. Journal of Applied Social Psychology 1993;23(14):1093-1110.
2. Wilson TE, Jaccard J, Levinson RA, Minkoff H, Endias R. Testing for HIV and other sexually transmitted diseases: implications for risk behavior in women. Health Psychol 1996;15(4):252-60.
3. Wilson TE, Jaccard J, Minkoff H. HIV-antibody testing: Beliefs affecting the consistency between women's behavioral intentions and behavior. Journal of Applied Social Psychology 1996;26(19):1681-1774.
4. Wilson TE, Minkoff H, McCalla S, Petterkin C, Jaccard J. The relationship between pregnancy and sexual risk taking. Am J Obstet Gynecol 1996;174(3):1033-6.
5. Wilson T, DeHovitz JA. STDs, HIV, and crack cocaine: a review. AIDS Patient Care STDS 1997;11(2):62-6.
6. Wilson TE, Minkoff H, DeHovitz J, Feldman J, Landesman S. The relationship of cocaine use and human immunodeficiency virus serostatus to incident sexually transmitted diseases among women. Sex Transm Dis 1998;25(2):70-5.
7. Hogben M, Wilson TE, Feldman J, Landesman S, DeHovitz J. The influence of HIV-related knowledge and exposure fears on behavior change and incident STDs. Women Health 1999;30(2):25-37.
8. Novotna L, Wilson TE, Minkoff HL, McNutt LA, DeHovitz JA, Ehrlich I, et al. Predictors and risk-taking consequences of drug use among HIV-infected women. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20(5):502-7.
9. Wilson TE, Augenbraun M. Sexually transmitted disease among women with HIV infection: a missed opportunity for intervention. AIDS Read 1999;9(8):573-7.
10. Wilson TE, Massad LS, Riester KA, Barkan S, Richardson J, Young M, et al. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study. AIDS 1999;13(5):591-8.
11. Wilson TE, Minkoff H. Mandatory HIV testing of infants and rates of follow-up care. Am J Public Health 1999;89(10):1583.
12. Fernandez MI, Wilson TE, Ethier KA, Walter EB, Gay CL, Moore J. Acceptance of HIV testing during prenatal care. Perinatal Guidelines Evaluation Project. Public Health Rep 2000;115(5):460-8.
13. Ickovics JR, Ethier KA, Koenig LJ, Wilson TE, Walter EB, Fernandez MI. Infant birth weight among women with or at high risk for HIV infection: the impact of clinical, behavioral, psychosocial, and demographic factors. Health Psychol 2000;19(6):515-23.
14. Augenbraun M, Wilson TE, Allister L. Domestic violence reported by women attending a sexually transmitted disease clinic. Sex Transm Dis 2001;28(3):143-7.
15. Royce RA, Walter EB, Fernandez MI, Wilson TE, Ickovics JR, Simonds RJ. Barriers to universal prenatal HIV testing in 4 US locations in 1997. Am J Public Health 2001;91(5):727-33.
16. St Lawrence JS, Wilson TE, Eldridge GD, Brasfield TL, O'Bannon RE, 3rd. Community-based interventions to reduce low income, African American women's risk of sexually transmitted diseases: a randomized controlled trial of three theoretical models. Am J Community Psychol 2001;29(6):937-64.
17. Wilson TE. Psychiatric morbidity among STD clinic patients: the need for screening and treatment. Sex Transm Dis 2001;28(5):285-6.
18. Wilson TE. Sexual and reproductive behavior of women with HIV infection. Clin Obstet Gynecol 2001;44(2):289-99.
19. Wilson TE, Ickovics JR, Fernandez MI, Koenig LJ, Walter E. Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states. Am J Obstet Gynecol 2001;184(6):1235-40.
20. Wilson TE, Minkoff H. Brief report: condom use consistency associated with beliefs regarding HIV disease transmission among women receiving HIV antiretroviral therapy. J Acquir Immune Defic Syndr 2001;27(3):289-91.
21. Wilson TE, Uuskula A, Feldman J, Holman S, Dehovitz J. A case-control study of beliefs and behaviors associated with sexually transmitted disease occurrence in Estonia. Sex Transm Dis 2001;28(11):624-9.
22. Cook JA, Cohen MH, Burke J, Grey D, Anastos K, Kirstein L, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr 2002;30(4):401-9.
23. Cook JA, Cohen MH, Grey D, Kirstein L, Burke J, Anastos K, et al. Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women. Am J Public Health 2002;92(1):82-7.
24. Ethier KA, Ickovics JR, Fernandez MI, Wilson TE, Royce RA, Koenig LJ. The Perinatal Guidelines Evaluation Project HIV and Pregnancy Study: overview and cohort description. Public Health Rep 2002;117(2):137-47.
25. Ickovics JR, Wilson TE, Royce RA, Minkoff HL, Fernandez MI, Fox-Tierney R, et al. Prenatal and postpartum zidovudine adherence among pregnant women with HIV: results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. J Acquir Immune Defic Syndr 2002;30(3):311-5.
26. Koenig LJ, Whitaker DJ, Royce RA, Wilson TE, Callahan MR, Fernandez MI. Violence during pregnancy among women with or at risk for HIV infection. Am J Public Health 2002;92(3):367-70.
27. Wilson TE, Barron Y, Cohen M, Richardson J, Greenblatt R, Sacks HS, et al. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis 2002;34(4):529-34.
28. Burke JK, Cook JA, Cohen MH, Wilson T, Anastos K, Young M, et al. Dissatisfaction with medical care among women with HIV: dimensions and associated factors. AIDS Care 2003;15(4):451-62.
29. Wilson TE, Koenig L, Ickovics J, Walter E, Suss A, Fernandez MI. Contraception use, family planning, and unprotected sex: few differences among HIV-infected and uninfected postpartum women in four US states. J Acquir Immune Defic Syndr 2003;33(5):608-13.
30. Wilson TE, Koenig LJ, Walter E, Fernandez I, Ethier K. Dual contraceptive method use for pregnancy and disease prevention among HIV-infected and HIV-uninfected women: the importance of an event-level focus for promoting safer sexual behaviors. Sex Transm Dis 2003;30(11):809-12.
31. Blaney NT, Fernandez MI, Ethier KA, Wilson TE, Walter E, Koenig LJ. Psychosocial and behavioral correlates of depression among HIV-infected pregnant women. AIDS Patient Care STDS 2004;18(7):405-15.
32. Cohen MH, Cook JA, Grey D, Young M, Hanau LH, Tien P, et al. Medically Eligible Women Who Do Not Use HAART: The Importance of Abuse, Drug Use, and Race. Am J Public Health 2004;94(7):1147-51.
33. Cook JA, Grey D, Burke J, Cohen MH, Gurtman AC, Richardson JL, et al. Depressive Symptoms and AIDS-Related Mortality Among a Multisite Cohort of HIV-Positive Women. Am J Public Health 2004;94(7):1133-40.
34. Kuo WH, Wilson TE, Holman S, Fuentes-Afflick E, O'Sullivan MJ, Minkoff H. Depressive symptoms in the immediate postpartum period among Hispanic women in three U.S. cities. J Immigr Health 2004;6(4):145-53.
35. Kuo WH, Wilson TE, Weber KM, Madhava V, Richardson J, Delapenha R, et al. Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the Women's Interagency HIV Study (WIHS). AIDS Patient Care STDS 2004;18(12):702-13.
36. Palacio H, Li X, Wilson TE, Sacks H, Cohen MH, Richardson J, et al. Healthcare use by varied highly active antiretroviral therapy (HAART) strata: HAART use, discontinuation, and naivety. AIDS 2004;18(4):621-30.
37. Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, et al. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis 2004;39(5):717-24.
38. Suss A, Homel P, Wilson TE, Shah B. Risk factors for nonfatal suicide behaviors among inner-city adolescents. Pediatr Emerg Care 2004;20(7):426-9.
39. Wilson TE, Gore ME, Greenblatt R, Cohen M, Minkoff H, Silver S, et al. Changes in sexual behavior among HIV-infected women after initiation of HAART. Am J Public Health 2004;94(7):1141-6.
40. Wilson TE, Ickovics JR, Royce R, Fernandez MI, Lampe M, Koenig LJ. Prenatal care utilization and the implementation of prophylaxis to prevent perinatal HIV-1 transmission. Matern Child Health J 2004;8(1):13-8.
41. Latka MH, Wilson TE, Cook JA, Bacon MC, Richardson JL, Sohler N, et al. Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women: a report from the Women's Interagency HIV Study. J Subst Abuse Treat 2005;29(4):329-37.
42. Burke-Miller JK, Cook JA, Cohen MH, Hessol NA, Wilson TE, Richardson JL, et al. Longitudinal Relationships Between Use of Highly Active Antiretroviral Therapy and Satisfaction With Care Among Women Living With HIV/AIDS. Am J Public Health 2006;96(6):1044-51.
43. Cook JA, Grey D, Burke-Miller J, Cohen MH, Anastos K, Gandhi M, et al. Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women. AIDS Care 2006;18(2):93-100.
44. Fuentes-Afflick E, Hessol NA, Bauer T, O'Sullivan MJ, Gomez-Lobo V, Holman S, et al. Use of prenatal care by Hispanic women after welfare reform. Obstet Gynecol 2006;107(1):151-60.
45. Gange SJ, Schneider MF, Grant RM, Liegler T, French A, Young M, et al. Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure. J Acquir Immune Defic Syndr 2006;41(1):68-74.
46. Koenig LJ, Whitaker DJ, Royce RA, Wilson TE, Ethier K, Fernandez MI. Physical and Sexual Violence During Pregnancy and After Delivery: A Prospective Multistate Study of Women With or at Risk for HIV Infection. Am J Public Health 2006;96(6):1052-9.
47. Schwartz RM, Malka ES, Augenbraun M, Rubin S, Hogben M, Liddon N, et al. Predictors of Partner Notification for C. trachomatis and N. gonorrhoeae: An Examination of Social Cognitive and Psychological Factors. J Urban Health 2006.
48. Wilson TE, Vlahov D, Crystal S, Absalon J, Klein SJ, Remein RH, et al. Integrating HIV prevention activities into the HIV medical care setting: a report from the NYC HIV Centers Consortium. J Urban Health 2006;83(1):18-30.
49. Cook JA, Grey DD, Burke-Miller JK, Cohen MH, Vlahov D, Kapadia F, et al. Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug Alcohol Depend 2007;89(1):74-81.
50. Massad LS, Evans CT, Wilson TE, Golub ET, Sanchez-Keeland L, Minkoff H, et al. Contraceptive use among U.S. women with HIV. J Womens Health (Larchmt) 2007;16(5):657-66.
51. Samuels TA, Minkoff H, Feldman J, Awonuga A, Wilson TE. Obstetricians, health attorneys, and court-ordered cesarean sections. Womens Health Issues 2007;17(2):107-14.
52. Wilson TE, Feldman J, Vega MY, Gandhi M, Richardson J, Cohen MH, et al. Acquisition of new sexual partners among women with HIV infection: patterns of disclosure and sexual behavior within new partnerships. AIDS Educ Prev 2007;19(2):151-9.
53. Wilson TE, Sharma A, Zilmer K, Kalikova N, Uuskula A. The HIV prevention needs of injection drug users in Estonia. Int J STD AIDS 2007;18(6):389-91.
54. Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, Jacobson LP. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis. 2007; 45(10):1377-85.
55. Wilson TE, Fraser-White M, Feldman J, Homel P, Wright S, King G, et al. Hair salon stylists as breast cancer prevention lay health advisors for African American and Afro-Caribbean women. J Health Care Poor Underserved 2008;19(1):216-26.
56. Kapadia F, Vlahov D, Wu Y, Cohen MH, Greenblatt RM, Howard AA, Cook JA, Goparaju L, Golub E, Richardson J, Wilson TE. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse. 2008;34(2):161-170.
57. Massad LS, Evans CT, Wilson TE, Golub ET, Goparaju L, Howard A, Greenblatt RM, Weber K, Schilder K. Impact of menopause on condom use by HIV-seropositive and comparison seronegative women. J Acquir Immune Defic Syndr 2008;47(3):401-2.
58. Hoffman S, Beckford S, Kelvin E, Wallace S, Augenbraun M, Hogben M, Liddon N, McCormack W, Rubin S, Wilson, T. West Indian Immigrant and US-Born Black STI Clinic Attendees: Comparison of HIV/STI Risk Behaviors, Self-Efficacy, Attitudes, and Intentions for Condom Use and Partner Notification of STI. American Journal of Public Health (in press).
59. Wilson T, Hogben M, Malka ES, Liddon N, McCormack WM, Rubin SR, Augenbraun MA. Reducing Sexually Transmitted Infection Rates by Improving Patient-Based Partner Notification for Treatment: A Randomized Controlled Trial. American Journal of Public Health (in press).
60. Schwartz RM, Augenbraun M, Rubin S, Hogben M, Liddon N, McCormack WM, Wilson T. Coping with a diagnosis of C trachomatis or N gonorrhoeae: Psychosocial and behavioral correlates. Journal of Health Psychology (in press).
61. Gardner L, Marks G, O’Daniels C, Wilson T, Golin C, Wright J, Quinlivan E, Bradley-Springer L, Thompson M, Thrun M. Implementation and evaluation of a clinic-based behavioral intervention: Positive STEPs for HIV patients. AIDS Patient Care and STDs (in press).
62. Cook R, Zhu F, Belnap B, Weber K, Cook J, Vlahov D, Wilson T, Hessol N, Plankey M, Howard A, Cole S, Sharp G, Richardson J, Cohen M. Longitudinal Trends in Hazardous Alcohol Consumption in Women with HIV Infection: 1995-2006. American Journal of Public Health (in press).
63. Cook J, Burke-Miller J, Cohen M, Cook R, Vlahov D, Wilson T, Golub E, Schwartz R, Howard A, Ponath C, Plankey M, Grey D. Crack cocaine, disease progression, and mortality in a multi-center cohort of HIV-1 positive women. AIDS (in press).